Anti-CD137 mAb Deletes Both Donor CD4^+ and CD8^+ T Cells in Acute Graft-versus-host Disease
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
We previously demonstrated that in vivo engagement of CD137, a member of TNF receptor superfamily, can delete allorective CD4^+ T cells through the induction of activation-induced cell death (AICD) in chronic graft-versus-host disease (cGVHD) and subsequently reverse established cGVHD. In this study, we further showed that agonistic anti-CD137 mAb was highly effective in triggering AICD of donor CD8^+ T cells as well as donor CD4^+ T cells in the C57BL/6→unirradiated (C57BL/6 × DBA/2)F1 acute GVHD model. Our results suggest that strong allostimulation should facilitate AICD of both alloreactive CD4^+ and CD8^+T cells induced by CD137 stimulation. Therefore, depletion of pathogenic T cells using agonistic anti-CD137 mAb combined with potent TCR stimulation may be used to block autoimmune or inflammatory diseases mediated by T cells.
Abstract
We previously demonstrated that in vivo engagement of CD137, a member of TNF receptor superfamily, can delete allorective CD4^+ T cells through the induction of activation-induced cell death (AICD) in chronic graft-versus-host disease (cGVHD) and subsequently reverse established cGVHD. In this study, we further showed that agonistic anti-CD137 mAb was highly effective in triggering AICD of donor CD8^+ T cells as well as donor CD4^+ T cells in the C57BL/6→unirradiated (C57BL/6 × DBA/2)F1 acute GVHD model. Our results suggest that strong allostimulation should facilitate AICD of both alloreactive CD4^+ and CD8^+T cells induced by CD137 stimulation. Therefore, depletion of pathogenic T cells using agonistic anti-CD137 mAb combined with potent TCR stimulation may be used to block autoimmune or inflammatory diseases mediated by T cells.
참고문헌 (7)
- 권병석, "CD137-CD137 Ligand Interactions in Inflammation", Immune Network, 9(3), pp.84~89 (2009), 대한면역학회
- Melero I, "Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors", Nat Med, 3, pp.682~685 (1997)
- Byungsuk Kwon, "Intervention with costimulatory pathways as a therapeutic approach for graft-versus-host disease", Experimental and Molecular Medicine, 42(10), pp.675~683 (2010), 생화학분자생물학회
- Kim J, "Stimulation with 4-1BB (CD137) inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor CD4+ T cells", Blood, 105, pp.2206~2213 (2005)
- Kim J, "Costimulatory molecule-targeted immunotherapy of cutaneous graft-versus-host disease", BLOOD, 110(3), pp.776~782, AMER SOC HEMATOLOGY
- Zhang B, "Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent", J Clin Invest, 117, pp.3029~3041 (2007)
- 로버트미틀러, "Dendritic Cells and Stat3 Are Essential for CD137-Induced CD8 T Cell Activation-Induced Cell Death", JOURNAL OF IMMUNOLOGY, 184(9), pp.4770~4778, AMER ASSOC IMMUNOLOGISTS